The Splice Between Gene Editing and Gene Therapy
Tacit Therapeutics launches with $19M to build RNA splicing therapies that fix mutations without touching DNA.
Category Highly Important
CRISPR Just Became an Antibiotic. Sort Of.
SNIPR Biome publishes first clinical proof that CRISPR-engineered phages can selectively kill bacteria in the human gut.